Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?
Article Details
- CitationCopy to clipboard
Pisani A, Riccio E, Sabbatini M
Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?
Genet Med. 2015 Jan;17(1):21-3. doi: 10.1038/gim.2014.79. Epub 2014 Jul 10.
- PubMed ID
- 25010055 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs